David Ritchie

Head of BMT

Australia

Research Interests

Explore related searches

Professors in Australia Professors in Immunology Immunology professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

David Ritchie is the Head of Bone Marrow Transplantation at the Royal Melbourne Hospital in Australia. His research areas include transplantation immunology, hematological malignancies, and post-transplant complications. Recent publications highlight emerging concepts in cytomegalovirus management during transplantation and the predictive role of JAK2 mutations in stem cell transplant relapse. His work also encompasses CAR T-cell therapies and the psychosocial impacts of hematopoietic stem cell transplantation.

Articles (19)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

View details

MARIA FTANOU

University of Melbourne

AUSTRALIA

View details

Amit Khot

Associate Professor

University of Melbourne

AUSTRALIA

View details

Michelle Yong

University of Melbourne

AUSTRALIA

View details

Professor and Head of Department

Australian National University

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

David Ritchie

Research Interests

Explore related searches

Contact this professor

About

Articles (19)

Emerging concepts of CMV in transplantation

Serial sensitive molecular detection of JAK2 V617F is predictive of relapse after allogeneic stem cell transplantation in patients with myelofibrosis

CAR T cells and time-limited ibrutinib as treatment for relapsed/refractory mantle cell lymphoma: the phase 2 TARMAC study

Bone Density and Trabecular Bone Score Decline Rapidly in the First Year After Bone Marrow Transplantation with a Marked Increase in 10-Year Fracture Risk

A phase 1 dose-escalation study of low-dose lenalidomide maintenance post-allogeneic stem cell transplantation for high-risk acute myeloid leukaemia or myelodysplastic syndrome

Choice of activation protocol impacts the yield and quality of CAR T cell product, particularly with older individuals

Compassionate access to virus-specific T cells for adoptive immunotherapy over 15 years

Evaluating the Feasibility and Acceptability of a Psychosexual Intervention for Couples Post-allogeneic Hematopoietic Stem Cell Transplantation

Modified cell trace violet proliferation assay preserves lymphocyte viability and allows spectral flow cytometry analysis

Allogeneic stem cell transplantation achieves long-term remissions in mantle cell lymphoma, including in TP53-mutated disease

A phase 1 clinical trial of the repurposable acetyllysine mimetic, n-methyl-2-pyrrolidone (NMP), in relapsed or refractory multiple myeloma

Diagnosis and management of endothelial disorders following haematopoietic stem cell transplantation

Predictors and outcomes of dose reduction of methotrexate and cyclosporin graft‐versus‐host disease prophylaxis following allogeneic haemopoietic cell transplantation

A Phase Ib/II Trial of Combined BRAF and EGFR Inhibition in BRAF V600E Positive Metastatic Colorectal Cancer and Other Cancers: The EVICT (Erlotinib and Vemurafenib In Combination Trial) Study

Centre-based comparison of double versus single prevention strategy on transfusion-transmitted cytomegalovirus in at-risk haemopoietic stem cell transplant patients and a state survey on cytomegalovirus-seronegative ordering practises

Consecutive day dosing of high-dose cytarabine consolidation over 3 days is resource-efficient and safe in older adult patients with acute myeloid leukemia

Early cessation of calcineurin inhibitors is feasible post–haploidentical blood stem cell transplant: the ANZHIT 1 study

Effective CMV prophylaxis with high-dose valaciclovir in allogeneic hematopoietic stem-cell recipients at a high risk of CMV infection

Non-viral pathogens of infectious diarrhoea post-allogeneic stem cell transplantation are associated with graft-versus-host disease

Collaborators (12)

Eric Youwei Wong

Chan Yoon Cheah

Misty Rayna Jenkins

anthony jaworowski

Constantine S. Tam

MARIA FTANOU

Amit Khot

Michelle Yong

Jeff Szer

Christopher Yates

Jayesh Desai

Elizabeth Gardiner

Make your next move.